Response to increasing doses of octreotide in a patient with carcinoid syndrome.
Ajani
J A
JA
Chesnut
J R
JR
D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008113:Liver Neoplasms / Q000556:secondary; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*
D006897:Hydroxyindoleacetic Acid; D015282:Octreotide